These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28512178)

  • 21. The need for new control strategies for particulate matter in parenterals.
    Poms J; Sacher S; Nixdorf M; Dekner M; Wallner-Mang S; Janssen I; Khinast JG; Schennach R
    Pharm Dev Technol; 2019 Jul; 24(6):739-750. PubMed ID: 30821571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Particulate Matter in Liquid-Finished Dosage Forms.
    Duchek J; Havasi B
    PDA J Pharm Sci Technol; 2018; 72(6):608-625. PubMed ID: 29853612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balancing Container Closure Integrity and Aesthetics for a Robust Aseptic or Sterile Vial Packaging System.
    Oni Y; Song X; Schrader M; Kulshrestha A; Franck J; Asselta R; Flores-Crespo C; Mantri RV
    PDA J Pharm Sci Technol; 2019; 73(6):572-587. PubMed ID: 31101708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visible Particulate Contamination Control for Injectable Products: A Life-Cycle Approach.
    Langille SE
    PDA J Pharm Sci Technol; 2020; 74(3):359-366. PubMed ID: 31732691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microscopic evaluation of pharmaceutical glass container-formulation interactions under stressed conditions.
    Ma Y; Ashraf M; Srinivasan C
    Int J Pharm; 2021 Mar; 596():120248. PubMed ID: 33486025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Conductivity Method as an Alternative to Titration for Hydrolytic Resistance Testing Used for Evaluation of Glass Vials Used in Pharmaceutical Industry.
    Fujimori K; Lee H; Phillips J; Nashed-Samuel Y
    PDA J Pharm Sci Technol; 2017 1/2; 71(1):50-58. PubMed ID: 27593692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on insoluble microparticulate contamination at ampoule opening].
    Kawasaki Y
    Yakugaku Zasshi; 2009 Sep; 129(9):1041-7. PubMed ID: 19721379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particulate matter in injectable drug products.
    Langille SE
    PDA J Pharm Sci Technol; 2013; 67(3):186-200. PubMed ID: 23752747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendation of Single Time Point Leachables Testing for Lyophilized Biotechnology Products Stored in Rubber Stoppered Glass Vial Systems.
    Gallegos A; Liu J; Ronk M; Qi L; Li K; Semin D; Nashed-Samuel Y
    J Pharm Sci; 2022 Jun; 111(6):1599-1604. PubMed ID: 35257694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of Glass Tubing Vials during Lyophilization.
    Machak DR; Smay GL
    PDA J Pharm Sci Technol; 2019; 73(1):30-38. PubMed ID: 30361283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel MATLAB®-Algorithm-Based Video Analysis to Quantitatively Determine Solution Creeping in Intact Pharmaceutical Glass Vials.
    Molnar D; Röhm M; Wutz J; Rivec I; Michel A; Klotz G; Hubbuch J; Schindowski K; Presser I
    Eur J Pharm Biopharm; 2022 Sep; 178():117-130. PubMed ID: 35961565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Vial Washing and Depyrogenation on Surface Properties and Delamination Risk of Glass Vials.
    Ditter D; Mahler HC; Gohlke L; Nieto A; Roehl H; Huwyler J; Wahl M; Allmendinger A
    Pharm Res; 2018 May; 35(7):146. PubMed ID: 29796727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting Sterilization-Induced Oxidation of Large Molecule Therapeutics Packaged in Plastic Parenteral Vials.
    Vieregg JR; Martin SJ; Breeland AP; Weikart CM; Tirrell MV
    PDA J Pharm Sci Technol; 2018; 72(1):35-43. PubMed ID: 28928291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations.
    Ayres JD
    PDA J Pharm Sci Technol; 2018; 72(6):626-639. PubMed ID: 30158238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Blow/Fill/Seal process variables in determining rate of vial contamination by air dispersed microorganisms.
    Leo F; Poisson P; Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 2005; 59(5):320-31. PubMed ID: 16316067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol.
    Perez M; Décaudin B; Abou Chahla W; Nelken B; Storme L; Masse M; Barthélémy C; Lebuffe G; Odou P
    Sci Rep; 2018 May; 8(1):7714. PubMed ID: 29769547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Particulate contamination associated with the manipulation of drugs in glass ampules: A literature review].
    Painchart L; Odou P; Bussières JF
    Ann Pharm Fr; 2018 Jan; 76(1):3-15. PubMed ID: 28800916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance Stability of Silicone Oxide-Coated Plastic Parenteral Vials.
    Weikart CM; Pantano CG; Shallenberger JR
    PDA J Pharm Sci Technol; 2017; 71(4):317-327. PubMed ID: 28416645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial Leaks in Container Closure Integrity Testing: Nonlinear Finite Element Simulation of Aperture Size Originated by a Copper Wire Sandwiched between the Stopper and the Glass Vial.
    Nieto A; Roehl H; Brown H; Adler M; Chalus P; Mahler HC
    PDA J Pharm Sci Technol; 2016; 70(4):313-24. PubMed ID: 27020649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glass vials for small volume parenterals: influence of drug and manufacturing processes on glass delamination.
    Ennis RD; Pritchard R; Nakamura C; Coulon M; Yang T; Visor GC; Lee WA
    Pharm Dev Technol; 2001 Aug; 6(3):393-405. PubMed ID: 11485181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.